Deep venous thrombosis prophylaxis in laparoscopy: An evidence-based review

Surgical Endoscopy and Other Interventional Techniques

Volumn 21, Issue 12, 2007, Pages 2335-2338

  Richardson, William S ^a   Apelgren, Keith ^b   Fanelli, Robert D ^c   Earle, David ^d  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c BERKSHIRE MEDICAL CENTER   (United States)

^d BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CONTINUOUS INFUSION; DEEP VEIN THROMBOSIS; HUMAN; LAPAROSCOPY; MEDLINE; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RATING SCALE; REVIEW; SURGICAL TECHNIQUE; THROMBOSIS PREVENTION; TREATMENT CONTRAINDICATION;

ANTICOAGULANTS; EVIDENCE-BASED MEDICINE; HEPARIN; HUMANS; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; LAPAROSCOPY; RISK ASSESSMENT; STOCKINGS, COMPRESSION; TIME FACTORS; VENA CAVA FILTERS; VENOUS THROMBOSIS; WARFARIN;

EID: 36248952099     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-007-9544-x     Document Type: Review

References (22)

1. Haas S, Flosbach CW (1993) Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemost 19 suppl 1:164-173
2. Nguyen NT, Owings JT, Gosselin R, Pevec WC, Lee SJ, Goldman E, Wolfe BM (2001) Systemic coagulation and fibrinolysis after laparoscopic and open gastric bypass. Arch Surg 136(8):909-916
3. Gonzalez QH, Tishler DS, Plata-Munoz JJ, Bondora A, Vickers SM, Leath T, Clements RH (2004) Incidence of clinically evident deep venous thrombosis after laparoscopic Roux-en-Y gastric bypass. Surg Endosc 18(7):1082-1084
4. Millard JA, Hill BB, Cook PS, Fenoglio ME, Stahlgren LH (1993) Intermittent sequential pneumatic compression in prevention of venous stasis associated with pneumoperitoneum during laparoscopic cholecystectomy. Arch Surg 128(8):914-918; discussion 918-919
5. Samama MM (2000) An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med 160(22):3415-3420
6. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton LJ (2002) 3rd Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 162(11):1245-1248
7. Blaszyk H, Bjornsson J. Factor V (2000) leiden and morbid obesity in fatal postoperative pulmonary embolism. Arch Surg 135(12):1410-1413
8. Haas S, Flosbach CW (1993) Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial. Semin Thromb Hemos 19 suppl 1:164-173
9. Nurmohamed MT, Verhaeghe R, Haas S, Iriarte JA, Vogel G, van Rij AM, Prentice CR, ten Cate JW (1995) A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 169(6):567-571
10. Anderson DR, O'Brien BJ (1997) Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolism. Pharmacoeconomics 12(1):17-29
11. Avikainen V, von Bonsdorff H, Partio E, Kaira P, Hakkinen S, Usenius JP, Kaaja R (1995) Low molecular weight heparin (Enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement. Annales chirurgiae et gynaecologiae 84:85-90
12. Clagett GP, Reisch JS (1988) Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg 208(2):227-240
13. Colditz GA, Tuden RL, Oster G (1986) Rates of venous thrombosis after general surgery: combined results of randomized clinical trials. Lancet 19:143-146
14. Miller MT, Rovito PF (2004) An approach to venous thromboembolism prophylaxis in laparoscopic roux-en-Y gastric bypass surgery. Obes Surg 14(6):731-737
15. Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity. Obes Sur. 13(6):819-825
16. Dunn CJ, Goa K (1996) Enoxaparin a pharmacoenconomic appraisal of its use in thromboembolic prophylaxis after total hip arthroplasty. Pharmacoeconomics 10(2):179-190
17. Leali A, Fetto J, Moroz A (2002) Prevention of thromboembolic disease after non-cemented hip arthroplasty. A multimodal approach. Acta Orthop Belg 68(2):128-134
18. Douketis JD, Kinnon K, Crowther MA (2002) Anticoagulant effect at the time of epidural catheter removal in patients receiving twice-daily low molecular-weight heparin and continuous epidural analgesia after orthopedic surgery. Thromb Haemost 88(1):37-40
19. Geerts WH, Pineo GF, Heit JA, Bergquist D, Lassen MR, Colwell CW, Ray JG (2004) Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):338s-400s
20. Kalve SP, Athanasoulis CA, Fan CM, Curvelo M, Geller SC, Greenfield AJ, Waltman AC, Wicky S (2006) "Recovery trade mark" vena cava filter: experience in 96 patients. Cardiovasc Intervent Radiol (epub ahead of print)
21. Scholten DJ, Hoedema RM, Scholten SE (2002) A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 12:19-24
22. Warkentin TE (2006) Hematology. Am Soc Hematol Educ Program 408-414